The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus

International Journal of Food Sciences and Nutrition

Volumn 65, Issue 4, 2014, Pages 515-520

  Arablou, Tahereh ^a   Aryaeian, Naheed ^b   Valizadeh, Majid ^c   Sharifi, Faranak ^c   Hosseini, Aghafatemeh ^b   Djalali, Mahmoud ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood sugar; Ginger; Inflammation; Insulin sensitivity; Serum lipids; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; AUTACOID; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; BLOOD; COMPLICATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; GINGER; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIAS; IMMUNOLOGY; INSULIN RESISTANCE; IRAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; RHIZOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GINGER; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; IRAN; LIPIDS; MALE; MIDDLE AGED; RHIZOME;

EID: 84901069925     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2014.880671     Document Type: Article

References (32)

1. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. 2006. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 96: 660-666.
2. Ali BH, Blunden G, Tanira MO, Nemmar A. 2008. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 46:409-420.
3. Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. 2008. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J 29: 1280-1284.
4. Atashak S, Piri M, Jafari A, Azarbayjani MA. 2010. Effects of 10 week resistance training and ginger consumption on C-reactive protein and some cardiovascular risk factors in obese men. PPJ (Iranian Society of Physiology and Pharmacology) 14:318-328.
5. Bhandari U, Kanojia R, Pillai KK. 2005. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 97:227-230.
6. Black C, Herring M, Hurley D, O'Connor P. 2010. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. Pain 11: 894-903.
7. Bordia A, Verma SK, Srivastava KC. 1997. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 56: 379-384.
8. ElRokh el-SM, Yassin NA, El-Shenawy SM, Ibrahim BM. 2010. Antihypercholesterolaemic effect of ginger rhizome (Zingiber offici-nale) in rats. Inflammopharmacology 18: 309-315.
9. Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. 2000. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 130:1124-1131.
10. Gao H, Guan T, Li C, Zuo G, Yamahara J, Wang J, Li Y. 2012. Treatment with ginger ameliorates fructose-induced fatty liver and hypertrigly-ceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway. Evid Based Complement Altern Med 2012: article ID 570948, doi:10.1155/2012/570948.
11. Goyal RK, Kadnur SV. 2006. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 77:160-163.
12. Habib SHM, Makpol S, Hamid NAA, Das S, Ngah WZW, YusofI YAM. 2008. Ginger extract (Zingiber Officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics 63: 807-813.
13. Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang M, Kawada T. 2008. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-a mediated down regulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem Biophys Res Commun 373:429-434.
14. Islam MS, Choi H. 2008. Comparative effects of dietary ginger (Zingiber officinale) and garlic (Allium sativum) investigated in a type 2 diabetes model of rats. J Med Food 11:152-159.
15. Kim S, Chun K, Kundu J, Surh Y. 2004. Inhibitory effects pg 6-gingerol on PMA-induced COX-2 expression and activation of NFkB and p38 MAPK in skin mouse. Biofactors 21:27-31.
16. Lantz RC, Chen GJ, Sarihan M, Solyom AM, Jolad SD, Timmermann BN. 2007. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 14:123-128.
17. Levy A, Simon O. 2009. Six-shogaol inhibits production of tumour necrosis factor alpha, interleukin-1 beta and nitric oxide from lipopolysaccharide- stimulated RAW 264.7 macrophages. West Indian Med J 58:295-300.
18. Li Y, Tran VH, Duke CC, Roufogalis BD. 2012. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Altern Med 2012: article ID 516870, doi:10.1155/2012/516870.
19. Mahluji S, Attari VE, Mobasseri M, Payahoo L, Ostadrahimi A, Golzari SE. 2013. Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. Int J Food Sci Nutr 2013. 64:682-686.
20. Nammi S, Sreemantula S, Roufogalis BD. 2009. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol 104:366-373.
21. Navarro JF, Mora C. 2006. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Sci World J 6:908-917.
22. Park K, Chun K, Lee S, Surh Y. 1998. Inhibitory effect of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 129:139-144.
23. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, et al. 2001. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42:2007-2014.
24. Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K. 2011. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin- induced diabetic rats. Food Chem Toxicol 49: 893-897.
25. Sharma I, Gusain D, Dixit VP. 1991. Hypolipidaemic and antiathero-sclerotic effects of plumbagin in rabbits. Indian J Physiol Pharmacol 35:10-14.
26. Shen C-L, Hong K-J, Kim SW. 2005. Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. J Med Food 8: 149-153.
27. Shimoda H, Shan SJ, Tanaka J, Seki A, Seo JW, Kasajima N, Tamura S, et al. 2010. Anti-inflammatory properties of red ginger (Zingiber officinale var. Rubra) extract and suppression of nitric oxide production by its constituents. J Med Food 13:156-162.
28. Shirdel Z, Mirbadalzadeh R, Madani H. 2009. Antidiabetic and antilipidemic effect of ginger in alloxan monohydrate diabetic rats in comparison with glibenclamide. Iran J Diabetes Lipid Disord 9:7-15.
29. Simin L, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, Heiss G, et al. 2007. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 167:1676-1685.
30. Singletary K. 2010. Ginger an overview of health benefits. Nutr Today 45:171-183.
31. Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. 2002. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 67:475-478.
32. Tripathi S, Bruch D, Kittur DS. 2007. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med 8: 1-7.